|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/06 | |||
| A61K 47/14 | |||
| A61K 9/06 | |||
| A61K 31/5575 |
| (11) | Number of the document | 3124015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16177742.0 |
| Date of filing the European patent application | 2014-05-09 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361822139 P | 2013-05-10 | US |
| (72) |
SINGER, Michael, S., US
KALAYOGLU, Murat, V., US
|
| (73) |
Topokine Therapeutics, Inc.,
241 Nahanton Street, Newton, MA 02459,
US
|
| (54) | COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT |
| COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT |